Skip to main content
Premium Trial:

Request an Annual Quote

Movers & Shakers: Sep 30, 2011

Premium

Vermillion has appointed Donald Munroe as chief scientific officer and vice president of research and development. Eric Fung, the company's former chief scientific officer, will now serve as chief medical officer.

Munroe was previously vice president of immunoassay research and development at Beckman Coulter. Before that he held several management roles at Invitrogen and worked in pharmaceutical discovery research experience at the R.W. Johnson Pharmaceutical Research Institute.

The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.